Journal of Veterinary Clinics (한국임상수의학회지)

The Korean Society of Veterinary Clinics (한국임상수의학회)
권호 표지

Long-term Chemotherapy with Hydroxyurea in a Dog with Suspected Intracranial Meningioma

  • Jung, Dong-In (College of Veterinary Medicine, Gyeongsang National University) ;
  • Lim, Chae-Young (College of Veterinary Medicine, Konkuk University) ;
  • Kang, Byeong-Teck (College of Veterinary Medicine, Konkuk University) ;
  • Kim, Ju-Won (College of Veterinary Medicine, Konkuk University) ;
  • Yoo, Jong-Hyun (BK21 Program of Integrative Network Systems for Veterinarians in Basic Science, Industrial Animals and Preventive Medicines, Konkuk University) ;
  • Park, Hee-Myung (College of Veterinary Medicine, Konkuk University)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

A 9-year-old female mixed breed dog was presented due to cluster seizure episode. A mass in the frontal lobe was noted on brain magnetic resonance imaging (MRI). The dural tail sign was identified on contrast MR images. Based on MRI findings, intracranial meningioma was suspected strongly. The patient's symptom was controlled well by a combination therapy of hydroxyurea and prednisolone, and survived for fourteen months after diagnosis. This case report demonstrated that the clinical findings, imaging characteristics of a dog with suspected intracranial meningioma and long-term survival after hydroxyurea plus prednisolone therapy.

Keywords

References

  1. Adamo PF, Forrest L, Dubielzig R. Canine and feline meningiomas: Diagnosis, treatment, and prognosis. Compen Contin Educat Pract Vet 2004; 26: 951-960
  2. Axlund TW, McGlasson ML, Smith AN. Surgery alone or in combination with radiation therapy for treatment of intracranial meningiomas in dogs: 31 cases (1989-2002). J Am Vet Med Assoc 2002; 221: 1597-1600 https://doi.org/10.2460/javma.2002.221.1597
  3. Bass MC, Schultze AE. Essential thrombocythemia in a dog: case report and literature review. J Am Anim Hosp Assoc 1998; 34: 197-203 https://doi.org/10.5326/15473317-34-3-197
  4. Gerritsen RJ, Teske E, Kraus JS, Rutteman GR. Multi-agent chemotherapy for mast cell tumors in the dog. Vet Q 1998; 20: 28-31
  5. Giordano F, Savarino A, Pagni CA. Spinal meningioma during hydroxyurea therapy. A paradoxical case report. Neurol Sci 2002; 23: 127-129 https://doi.org/10.1007/s100720200039
  6. Jung DI, Kim HJ, Park C, Kim JW, Kang BT, Lim CY, Park EH, Sur JH, Seo MH, Hahm DH, Park HM. Longterm chemotherapy with lomustine of intracranial meningioma occurring in a Miniature schnauzer. J Vet Med Sci 2006; 68: 383-386 https://doi.org/10.1292/jvms.68.383
  7. Jung DI, Park C, Kang BT, Kim JW, Kim HJ, Lim CY, Jeong SW, Park HM. Acquired cervical syringomyelia secondary to a brainstem meningioma in a Maltese dog. J Vet Med Sci 2006; 68: 1235-1238 https://doi.org/10.1292/jvms.68.1235
  8. Leifer CE, Matus RE, Patnaik AK, MacEwen EG. Chronic myelogenous leukemia in the dog. J Am Vet Med Assoc 1983; 183: 686-689
  9. Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A. Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neuro-Oncol 2004; 67: 221-226 https://doi.org/10.1023/B:NEON.0000021827.85754.8e
  10. MacEwen EG, Drazner FH, McClelland AJ, Wilkins RJ. Treatment of basophilic leukemia in a dog. J Am Vet Med Assoc 1975; 166: 376-380
  11. Marconato L, Bonifanti U, Fileccia I. Unusual dermatological toxicity of hydroxyurea in two dogs with spontaneously occurring tumors. J Small Anim Pract 2007; 48: 514-517 https://doi.org/10.1111/j.1748-5827.2006.00301.x
  12. Moore KW, Stepien RL. Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patient ductus arteriosus in 4 dogs. J Vet Intern Med 2001; 15: 418-421 https://doi.org/10.1892/0891-6640(2001)015<0418:HFTOPS>2.3.CO;2
  13. Newton HB, Slivka MA, Stevens C. Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neuro-Oncol 2000; 49: 165-170 https://doi.org/10.1023/A:1026770624783
  14. Perkins M, Watson A. Successful treatment of hypereosinophilic syndrome in a dog. Aust Vet J 2001; 79: 686- 689 https://doi.org/10.1111/j.1751-0813.2001.tb10671.x
  15. Rosenthal MA, Ashley DL, Cher L. treatment of high risk or recurrent meningiomas with hydroxyurea. J Clinic Neurosci 2002; 9: 156-158 https://doi.org/10.1054/jocn.2001.1019
  16. Schrell UMH, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, Fahlbusch R. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 1997; 86: 845-852 https://doi.org/10.3171/jns.1997.86.5.0845
  17. Schrell UMH, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F, Fahlbusch R. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 1997; 86: 840-844 https://doi.org/10.3171/jns.1997.86.5.0840
  18. Snyder JM, Shofer FS, Van Winkle TJ, Massicotte C. Canine intracranial primary neoplasia: 173 cases (1986- 2003). J Vet Intern Med 2006; 20: 669-675 https://doi.org/10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2
  19. Tamura S, Tamura Y, Ohoka A, Hasegawa T, Uchida K. A canine case of skull meningioma treated with hydroxyurea. J Vet Med Sci 2007; 69: 1313-1315 https://doi.org/10.1292/jvms.69.1313
  20. Turrel JM, Fike JR, LeCouteur RA, Pflugfelder CM, Borcich JK. Radiotherapy of brain tumors in dogs. J Am Vet Med Assoc 1984; 184: 82-86